Luc J. W. van der Laan, PhD
Associate Professor, Head LETIS

Contact details:
Room L-458

Send an email

Luc J.W. van der Laan studied Biology at the University of Amsterdam and receiving his PhD degree at the Vrije University in Amsterdam (1998). As a fellow he worked for three years at the Scripps Research Institute, La Jolla, California, on the xeno-infectious risk of porcine pancreatic islet transplantation. In 2000 he received a post-doc fellowship from the Dutch Science Organization (NWO) to work at the Sanquin Research Institute, Amsterdam. In 2002 he became staff researcher at the Erasmus MC-University Medical Center Rotterdam and positioned at the Laboratory of Gastroenterology & Hepatology to continue research on transplantation and viral infections. In 2010 he was appointed associate professor and head of the new Laboratory of Experimental Transplantation and Intestinal Surgery, LETIS, at the department of Surgery. LETIS accommodates research on infection, tissue injury and repair in organ transplantation and the gastrointestinal tract.

Luc van der Laan served as Associated Editor for Liver Transplantation and is currently on the editorial board of Liver Transplantation and the World Journal of Gastroenterology. He is a member of the scientific committee of the Dutch Najjar Society and in 2007 was appointed as chair of the International Society of Liver Transplantation (ILTS) Basic Science Committee. He received several awards including the ESOT "Best abstract in basic science" (2005) and three times the ILTS "Rising Star" Award (2005, 2006, 2009).

• van der Laan LJW., C. Lockey, B.C. Griffeth, F.S. Frasier, C.A. Wilson, D.E. Onions, B.J. Hering, Z. Long, E. Otto, B.E. Torbett and D.R. Salomon Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice.
  Nature 407: 90-94(2000)
• Henry SD, HJ Metselaar, RCB Lonsdale, A Kok, BL Haagmans, HW Tilanus and van der Laan LJW
  Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-a.
  Gastroenterology 131, 1452-1462 (2006)
  
• Demirkiran, A., B.M. Bosma, A. Kok, C.C. Baan, H.J. Metselaar, J.N.M. IJzermans, H.W. Tilanus, J. Kwekkeboom and van der Laan LJW
  Allo-suppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation.
  J. Immunol. 178: 6066-72 (2007)
  
• Henry SD, van der Wegen PG, Metselaar HJ, Scholte BJ, Tilanus HW and van der Laan LJW
  Hydroxyethyl starch-based preservation solutions enhance gene therapy vector delivery under hypothermic conditions
  Liver Transplantation 14:1708-17 (2008)
• Demirkiran A, T. Hendrix, CC Baan and van der Laan LJW
  Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: Does in vitro evidence translate to the clinical setting?
  Transplantation 85:783-9(2008)
• Boonstra A, van der Laan LJW, Vanwolleghem T, Janssen HL.
  Experimental models for hepatitis C viral infection.
  Hepatology 50:1646-55(2009)
• Pan Q, HW Tilanus, HLA Janssen and van der Laan LJW
  Prospects of RNAi and microRNA-based therapies for hepatitis C.
  Expert Opinion on Biological Therapy 9:713-24(2009)
  
  
  

Do a PubMed search for references by Luc van der Laan.

Back